DEH 113
Alternative Names: DEH-113Latest Information Update: 23 Aug 2024
At a glance
- Originator EMS
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dysmenorrhoea
Most Recent Events
- 15 Aug 2024 EMS plans clinical trial for Dysmenorrhea in September 2024 (Ref), (NCT06555549)
- 27 Feb 2024 Preclinical trials in Dysmenorrhoea in Brazil (PO), prior to February 2024 (EMS pipeline, February 2024)
- 22 Feb 2024 EMS plans a phase III LIBERTA trial for Dysmenorrhea in February 2025 (PO) (NCT06268054)